Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by prophetoffactz


T.MBX

COVID

@COVID19_disease As of August 26, 2024, the U.S. is grappling with an...

August 27, 2024

T.CSCI

What could an additional trial, if needed, look like?

Perplexity Ai: Based on the top-line results of the DETECT trial, an...

August 27, 2024

T.CSCI

RE:More de-risked and more needed than ever?

With macimorelin's safety de-risked and maybe even more needed than ever...

August 27, 2024

T.CSCI

More de-risked and more needed than ever?

What could macimorelin be sold for with "excellent safety" now...

August 27, 2024

T.CSCI

Yeast beta glucan and Alzheimer's

Int J Biol Macromol     ...

August 27, 2024

T.CSCI

Being asset rich the company has options.

This company is asset rich and is still before a number of potential...

August 27, 2024

V.SPN

Record bookings backlog, return to EBITDA positive and...

Atul Sabharwal continued, "Looking ahead, we are poised for a strong...

August 27, 2024

T.CSCI

RE:Adult trial failed to meet primary endpoint but was approved

fossi, why not provide your analysis for how the other tests concluded the...

August 27, 2024

T.CSCI

Adult trial failed to meet primary endpoint but was approved

For the adult trial: In January 2017, Aeterna Zentaris announced that the...

August 27, 2024

T.CSCI

RE:RE:New Press Release - COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

lscfa wrote: Who's the bonehead designing these studies?  Why not do...

August 27, 2024

T.CSCI

If the industry is falsely over-diagnosing children

with growth hormone deficiency with those other tests does it have a problem?

August 27, 2024

T.CSCI

Perplexity Ai:

Based on the information provided, there is a strong case for the FDA to...

August 27, 2024

T.CSCI

Perplexity Ai

Based on the unexpected results from the DETECT trial, there are a few...

August 27, 2024

T.CSCI

Perplexity Ai:

Based on the press release, it appears that the Phase 3 DETECT trial of...

August 27, 2024

T.CSCI

RE:RE:The unexpected

Schellaj wrote: And yet CSCI is down almost 50% on the American market this...

August 27, 2024

T.CSCI

RE:The unexpected

The other industry tests may be worse than the industry expects and falsely...

August 27, 2024

T.CSCI

The unexpected

1) Excellent safety was confirmed: "The top-line results confirm the...

August 27, 2024

T.CSCI

RE:RE:Perplexity Ai's expectations for pediatric trial results

Are these valid expectations? The pediatric trial compares macimorelin...

August 27, 2024

T.CSCI

RE:Perplexity Ai's expectations for pediatric trial results

After feeding Perplexity Ai more info about the dose finding pediatric trial...

August 26, 2024

T.CSCI

Perplexity Ai's expectations for pediatric trial results

I asked what sensitivity/specificity Perplexity Ai expected from the...

August 26, 2024

Featured Company